FINWIRES · TerminalLIVE
FINWIRES

There's No Spring In Canada's Home Sales Market, Says BMO

-- Canada's housing market has yet to come out of winter hibernation, with sales subdued and prices still drifting lower at the national level, said Bank of Montreal (BMO).

Market conditions continue to vary significantly by region, but the big picture is that national housing momentum has yet to pick up, noted the bank after Thursday's Canadian Real Estate Association (CREA) data.

BMO continued to wait for the spring season for a clearer view, but still expects soft activity for most of the year.

Existing home sales were effectively flat in seasonally-adjusted terms in March at 0.1% month-over-month lower, and were down 2.3% from year-ago levels. The level of sales activity is still running very low, at roughly 17% below the 10-year average, with raw March activity the weakest for that month since the 2009 recession.

New listings also dipped 0.2% in the month and were down 4.9% from a year ago.

That left the sales-to-new listings ratio little changed at 47.8%, reflecting still-balanced overall national conditions, the bank pointed out. The coming months will be a good test of market balance, with some pent-up demand meeting pent-up listings that didn't sell since the fall.

How those two sides interact will determine if the market can tighten up through the rest of the year. Suffice it to say that when you're on the floor, the next direction is, eventually, higher, added BMO.

The national benchmark price slipped again in March and was down 4.7% year over year from a year ago. Short-term momentum hasn't improved much either, with the three-month annualized decline running at 7%.

After the initial deep correction, prices are now in the process of slowly "bleeding" until affordability is restored, according to the bank.

Related Articles

Research

Research Alert: CFRA Maintains Buy Rating On Shares Of Quest Diagnostics

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We keep our 12-month price target at $235. This is based on a forward P/E of 21.9x our 2026 EPS estimate, a premium to DGX's three-year forward average of 16.8x due to our view of strengthening sales and earnings growth, backed by higher health care utilization trends and some regulatory relief due to postponement of lab reimbursement cuts until at least 2027. We think lab testing providers remain a relatively well-positioned area within health care given lower policy risks, supportive testing demand, and attractive earnings growth potential. On a compounded annual basis from 2025-2028, we expect near 8% EPS growth, raising our 2026 EPS to $10.73 from $10.60 and 2027 EPS to $11.50 from $11.42. We also anticipate additional smaller M&A opportunities, along with healthy dividend increases (recent 7.5% boost; shares yield 1.7%) as cash flow generation remains supportive over the near term.

$DGX
Research

Research Alert: Pega: Q1 Results Miss, But Strength In Pega Cloud Offsets

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:PEGA reported total revenue of $430M, missing consensus by $37.2M and declining 10% Y/Y, while non-GAAP EPS of $0.46 missed by $0.23 and fell 39% Y/Y. However, Pega Cloud revenue surged 36% Y/Y to $205M, now representing 47.7% of total revenue and validating the cloud transition thesis. Pega Cloud annual contract value (ACV) acceleration remains the standout metric, growing 29% Y/Y to $906.7M and accelerating from 23% growth in Q1, demonstrating continued strong demand for the company's AI workflow automation platform. Total ACV grew 12% Y/Y to $1.62B, with backlog increasing 16% Y/Y to $2.01B providing revenue visibility. We believe the robust cash flow generation of $206.5M in free cash flow and a solid balance sheet with $474M in cash provides financial flexibility for continued AI investment. Despite near-term profitability pressure, we expect the sustained Pega Cloud momentum and strong ACV growth to support the business transformation.

$PEGA
Asia

Air New Zealand CFO to Resign

Air New Zealand (ASX:AIZ, NZE:AIR) said that Chief Financial Officer Richard Thomson has resigned, effective Aug. 28, according to a Wednesday filing with the New Zealand bourse.The airline has started the process of searching for a new CFO, the filing added.

$ASX:AIZ$NZE:AIR